Antitumor therapy comprising distamycin derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) C07D 403/14 (2006.01)

Patent

CA 2424116

The present invention relates to an administration schedule comprising the intravenous administration of a .alpha.-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.

L'invention concerne un schéma de prescription comprenant l'administration intraveineuse d'un dérivé d'.alpha.-halogène-acryloyl distamycine ou d'un sel pharmaceutiquement acceptable de celui-ci. L'administration précitée permet le traitement d'une variété de tumeurs chez les mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antitumor therapy comprising distamycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor therapy comprising distamycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor therapy comprising distamycin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1468178

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.